ZymoGenetics, Inc.
DN1BMC
Recommendation
Dividend Power Score
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
--
Corporate Info
Website
--
Phone Number
(206) 442-6600
Address
1201 Eastlake Avenue East
Seattle, WA 98102-3702
Seattle, WA 98102-3702
Country
United States
Year Founded
1981
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
Business Description
ZymoGenetics, Inc. develops, manufactures, and commercializes therapeutic proteins for the treatment of human diseases. It offers RECOTHROM Thrombin, a topical recombinant for aiding hemostasis; PEG-Interferon lambda for the treatment of hepatitis C virus infection; IL-21 for the treatment of metastatic melanoma; and anti-IL-31 monoclonal antibody for the treatment of atopic dermatitis. It offers research on discovery and advancement of therapeutic proteins with potential applications in immuno-oncology diseases. The company was formerly known as Zymos Corporation. ZymoGenetics, Inc. was founded in 1981 and is based in Seattle, Washington. As of October 7, 2010, ZymoGenetics, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.